| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/26/2004 | EP1420773A1 Amidine derivatives for treating amyloidosis |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420771A2 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 05/26/2004 | EP1420769A2 Lipid profile modulation with steroids |
| 05/26/2004 | EP1420768A2 Methods and compositions for regulating memory consolidation |
| 05/26/2004 | EP1420729A2 Stent vascular intervention device and method |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1313499A4 Method for treating the central nervous system by administration of igf structural analogs |
| 05/26/2004 | EP1303478B1 Process for the preparation of substituted octanoyl amides |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1131050B1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP1022272B1 Substituted fused heterocyclic compounds |
| 05/26/2004 | EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0561977B1 Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1500090A Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1498964A Serial recombined gland related virus inducible path of RNAi, and utilized in gene therapy |
| 05/26/2004 | CN1498656A Method and compsn. of nervous regulation protein for treating myocardial infarction |
| 05/26/2004 | CN1498647A Crocodile heart-invigoration pill |
| 05/26/2004 | CN1498645A Capsule of Chinese traditional medicine for treating cerebral thrombosis and coronary heart disease as well as its prepn. method |
| 05/26/2004 | CN1498641A Liniment of Chinese traditional medicine for treating hemiplegia |
| 05/26/2004 | CN1498637A Combination medication for curing angeitis |
| 05/26/2004 | CN1498622A Neurotoxicity inhibiting compsns. contg. ginsenoside Rg3 or ginsenoside Rh2 transferring glu |
| 05/26/2004 | CN1498615A Preparation made from effective position of red sage root, and its prepn. method |
| 05/26/2004 | CN1498527A Method for producing breed of paddy capable of decreasing blood pressure |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/26/2004 | CN1151152C New polycyclicazindole compound, its preparation method are medicine composition containing same |
| 05/26/2004 | CN1151150C Non-peptide angiotonin II receptor antagon Jw sartan compounds and its synthesizing process and application |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/26/2004 | CN1150944C Application of alkaline fibroblast growth factor in preparing medicine to prevent and cure cerebral injury |
| 05/26/2004 | CN1150932C Intravenous injection of curing cardiovascular system diseases and its preparing method |
| 05/26/2004 | CN1150930C Cinnamon twig decoction extract for preventing and curing hypertension |
| 05/26/2004 | CN1150915C Prescription of'strong heart first-aid dropping pill'and its preparing process |
| 05/26/2004 | CN1150910C Instant bee pollen and its preparing process |
| 05/26/2004 | CN1150909C Medicine for treating cerebral thrombus and its preparing process |
| 05/26/2004 | CN1150907C Usage of turtle oil, and trionxy oil |
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740772 Pgd2 agonists; sleep inducing action; intracerebral transition; stability |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740657 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740648 Using a vasopressin antagonist such as conivaptan |
| 05/25/2004 | US6740644 Chemical compounds |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | CA2342283C Recombinant adenovirus for tissue specific expression in heart |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/25/2004 | CA2029419C Nmda-blocking pharmaceutical compositions |
| 05/21/2004 | WO2004042402A2 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 05/21/2004 | WO2004042076A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 05/21/2004 | WO2004041814A1 Heteroaryl-pyramidine derivatives as jak inhibitors |
| 05/21/2004 | WO2004041812A1 Therapeutic compounds and methods |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041302A1 Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator |
| 05/21/2004 | WO2004041301A1 Antidiuretics |
| 05/21/2004 | WO2004041296A2 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 05/21/2004 | WO2004041290A1 Use of fosinopril to reduce cardiovascular events in dialysis patients |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041270A1 Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041265A1 Blood fluidity improving agent |
| 05/21/2004 | WO2004041245A2 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 05/21/2004 | WO2004021973A3 Pravastatin pharmaceutical formulations and methods of their use |
| 05/21/2004 | WO2004018473A3 Azapurine derivatives |
| 05/21/2004 | WO2004014222A3 Diagnosis and treatment of tuberous sclerosis |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |